Skip to content

Chest Imaging, Breath, and Biomarkers in a Screening Trial

A Clinical Trial to Develop Chest Imaging, Breath, and Biomarkers in a Screening Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01663155
Enrollment
1424
Registered
2012-08-13
Start date
2008-09-30
Completion date
2014-05-31
Last updated
2017-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

lung cancer, chest x-ray, CT scan, computer aided detection (CAD), screening, smokers

Brief summary

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Detailed description

The fight against lung cancer is waged on three major fronts: prevention, detection and treatment. Our goal is to determine if chest x-rays,computer aided detection (CAD)and a CT scan can detect disease earlier when treatment is more effective. If we improve the detection of disease, we will see if screening reduces the incidence of symptomatic advanced lung cancer relative to no screening in people at high risk to develop lung cancer.

Interventions

DEVICEchest x-ray with or without CAD, lose dose CT scan

PA view, low dose CT scan

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* ages 40-75 years * If ages 40-59, then one of the following criteria needs to be met: * Current or ex-smoker with \>25 pack years and a family history of lung cancer(parent or sibling) OR * current or ex-smoker with \> 25 pack years and COPD OR * current or ex-smoker with a \> 35 pack year history * If ages 60-75, then one of the following additional criteria needs to be met: * Current or ex-smoker with \>25 pack years and a family history of lung cancer (parent or sibling) OR * Current or ex-smoker with \>25 pack years and COPD OR * Current or ex-smoker with a \>30 pack year history * Subject is able to return to Cleveland Clinic for annual follow-up screening * Subject is willing to sign a medical release form

Exclusion criteria

* Current health requires oxygen * Have had a chest x-ray or CT of the chest within the last 6 months * Previous pneumonectomy * Lobectomy of the lung within the last 5 years * Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer, carcinoma in situ of the cervix and localized prostate cancer * A medical condition that would prevent treatment for lung cancer * Within the last 6 weeks, one of the following has occured: * A new cough or chronic cough that has gotten worse * Either new shortness of breath, or any worsening of shortness of breath * A cough producing blood * Constant chest pain * Respiratory infection, pneumonia, or cold * Unintentional and unexplained weight loss greater than 5% of total body weight

Design outcomes

Primary

MeasureTime frameDescription
The sensitivities of chest x-ray with CAD and chest CTOne year after scanThe false positive rates of chest x-ray with CAD and chest CT will be compared. The analysis will be based on the study subjects from this prospective study who test positive with chest x-ray and/or CT and who are determined not to have lung cancer during the follow-up period.

Secondary

MeasureTime frameDescription
The quality of life between screening with chest x-ray and CAD versus no screening.One year after scanQuality of life between the chest x-ray group and the CAD group
Disease-specific mortality between screening with chest x-ray and CAD versus no screeningOne year after scanMortality rate in screening x-ray vs CAD
All-cause mortality rate between screening with chest x-ray and CAD versus no screeningOne year after scanAll cause mortality rate
Length of time between randomization and the incidence of symptomatic advanced lung cancer for screened subjects versus controlsOne year after scanTime between randomization and symptom
Does lung cancer screening with chest x-rays and computer aided detection (CAD) reduce the incidence of symptomatic advanced lung cancer in a high risk populationOne year after scanCancer detection rate between chest x-ray and CAD

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026